Skip to main content

Paras Biologics Finland

  • | Biotech or pharma, therapeutic R&D
  • | CMO, CRO
Paras Biologics Finland

Paras Biopharmaceuticals Finland specializes in microbial-based biologics, leveraging proprietary technologies like Diabrid®, Noblecleav®, and Cytofold StructQuant® to produce complex recombinant proteins efficiently.


Established in 2012, the company focuses on biosimilar development (e.g., Romiplostim, Teriparatide, Anakinra), recombinant bioprocess enzymes (RapidEK® and RapidTEV®), and CDMO services for microbial biologics.


With a state-of-the-art facility in Finland, Paras Biopharma provides end-to-end solutions from feasibility studies to large-scale manufacturing. Recognized by global clients for delivering high-quality biologics,


Paras Biopharma is committed to advancing therapies for oncology, rare diseases, and metabolic disorders.

Address

Oulu
Finland
Visit website

Contact Exhibitor


Loading
View all Exhibitors
Testimonials

Double Helix


 

Supporting Bank Sponsor


 

Premier Sponsors

Conference Sponsors